Invention Grant
- Patent Title: Compounds and compositions as inhibitors of endosomal toll-like receptors
-
Application No.: US16330820Application Date: 2017-09-06
-
Publication No.: US10954233B2Publication Date: 2021-03-23
- Inventor: Phillip Alper , Jonathan Deane , Songchun Jiang , Tao Jiang , Thomas Knoepfel , Pierre-Yves Michellys , Daniel Mutnick , Wei Pei , Peter Syka , Guobao Zhang , Yi Zhang
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Francine F. Li
- International Application: PCT/IB2017/055375 WO 20170906
- International Announcement: WO2018/047081 WO 20180315
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; A61K31/4375 ; A61P17/06 ; A61P1/16 ; A61P37/06 ; A61P19/02 ; A61K31/496 ; A61K31/519 ; A61K31/5377 ; A61K31/541 ; A61K45/06
Abstract:
The invention disclosed herein relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridinyl compounds and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridinyl compounds of Formula (A), pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of autoimmune diseases.
Public/Granted literature
- US20190211009A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS Public/Granted day:2019-07-11
Information query
